Anagrelide
Uses of Anagrelide
Anagrelide is commonly used to treat Essential Thrombocytopenia
How Anagrelide Works
Anagrelide is a cyclic adenosine monophosphate phosphodiesterase III inhibitor. It reduces platelet production and inhibits platelet aggregation at high concentrations such as in patients with Essential Thrombocytopenia.
Side Effects of Anagrelide
Anaemia, Fluid retention, Dizziness, Tachycardia, Palpitation Diarrhea, vomiting, flatulence, abdominal pain, Rash, Fatigue
Warnings
Kidney High Risk
Anagrelide is contraindicated in patients with moderate to severe kidney disease especially with less than CrC 50mL/min.
Alcohol Not Advisable
It is unsafe to consume alcohol with Anagrelide. Taking Anagrelide may lead to side effects such as dizziness, fatigue and tachycardia or palpitations. Hence, consumption of both Alcohol and Anagrelide may lead to additive effects that could be dangerous.
Pregnancy Not Safe
Anagrelide may be unsafe to use during pregnancy. Animal studies showed toxicity to the fetal development, however, there are limited human studies regarding the effect of Anagrelide on fetus. It should only be used if benefits outweigh the risks. Please consult your doctor.
Driving Not advisable
Anagrelide commonly cause dizziness. If patient experiences side effects such as dizziness, it is not advisable to drive a car or operate machinery.
Liver High Risk
Anagrelide is contraindicated in patients with liver failure. Please consult your doctor.
Lactation Limited Data
Excretion of Anagrelide in human milk is unknown. Available data in animals have shown excretion of Anagrelide/metabolites in milk. Breast-feeding should be discontinued during treatment with Anagrelide as the risk to the newborn/infant cannot be excluded.
Frequently Asked Questions
Written by Dr Sri Viknarajan, MD (Universiti Hasanuddin, Indonesia)
Reviewed by Dr Nur Syuhada binti Zulkifli, MD, Universiti Kebangsaan Malaysia (UKM).
